Medical Device Feasibility Study: 6 Questions to Answer Before Investing in a Prototype
A medical device feasibility study evaluates whether a proposed healthcare product is clinically relevant, technically achievable, safe, commercially viable and practical to manufacture. Before investing in a prototype, founders should assess six areas: clinical need, technical feasibility, regulatory requirements, safety risks, manufacturing feasibility and commercial viability.
A feasibility study does not eliminate uncertainty. It helps identify which assumptions need evidence before significant development resources are committed.
Why a Working Prototype Isn't Always Proof of a Viable Medical Device
A clinician identifies a problem during a routine procedure.
The existing equipment is difficult to operate, the process takes longer than necessary, or a particular clinical need is not being addressed effectively.
An idea emerges for a better device.
The clinician discusses it with an engineering team. Initial sketches are prepared, components are shortlisted and the first prototype begins taking shape.
A few months later, the prototype works.
But the team now discovers that the selected material may not be suitable for the intended application. The design is difficult to manufacture consistently. A critical component is expensive to source, and the regulatory requirements are more extensive than originally anticipated.
The product may still be worth developing, but the team has already invested time and money before resolving some of its most important uncertainties.
This is where a medical device feasibility study can make a difference.
At Inspire Design, having worked across 60+ healthcare product development projects, we've seen how decisions made during the early stages of development influence everything that follows, from engineering and prototyping to manufacturing preparation.
The objective of feasibility assessment is not to establish that every detail will work perfectly. It is to determine whether there is sufficient evidence to justify the next investment.
Here are six questions worth answering before moving into prototype development.
1. Is There a Clearly Defined Clinical Problem Worth Solving?
Medical device development should begin with the clinical need rather than the proposed technology.
A founder may have an interesting product concept, but that does not necessarily mean the intended users need it.
Consider a handheld diagnostic device designed to simplify an existing procedure.
The concept looks promising, but before development begins, the team needs to understand how the procedure is currently performed.
How much time does it take? What equipment is used? Which steps create difficulties? How frequently does the problem occur? Who would benefit from the proposed improvement?
These questions help establish whether the product addresses a genuine clinical or operational need.
A useful feasibility assessment should involve conversations with the people who will actually use the device.
For example, a surgeon may identify a clinical problem, but nurses, technicians and biomedical engineering teams may reveal practical constraints that affect how the product should be designed.
The person proposing the device is not always the only person whose requirements matter.
Clinical observations also need to be translated into measurable product requirements.
A statement such as "the device should be easier to use" is a useful starting point, but it is not sufficient for engineering development.
The team needs to understand what easier means in practice. It might involve reducing the number of operating steps, improving grip, simplifying setup or making the device usable within a particular clinical environment.
Before investing in a prototype, establish who experiences the problem, how often it occurs and what measurable improvement the proposed device should deliver.
2. Can the Medical Device Be Built With Available Technology?
Technical feasibility evaluates whether the proposed medical device can achieve its intended functionality using a practical combination of engineering methods, materials, components and technologies.
An idea may be clinically valuable but technically difficult to implement.
Consider a wearable device intended to monitor a physiological parameter continuously.
The sensing technology may already exist, but incorporating it into a compact, comfortable and reliable product creates additional challenges.
The engineering team may need to evaluate sensor accuracy, power consumption, battery life, signal quality, connectivity and the physical constraints of the device.
A sensor that performs well on a laboratory bench may behave differently once integrated into a wearable enclosure.
Similarly, a mechanism that functions during a controlled demonstration may not withstand repeated use.
Technical feasibility should therefore consider the complete system rather than individual components in isolation.
Depending on the product, this may involve:
Assessing available sensing, mechanical or electronic technologies
Evaluating component dimensions and integration requirements
Reviewing power consumption and thermal constraints
Identifying software and connectivity requirements
Testing critical engineering assumptions through simulations or small experiments
Evaluating the availability and reliability of key components
One of the most useful outcomes of a feasibility study is identifying the technical assumptions that present the greatest risk.
If the entire product depends on a particular sensor achieving a specified level of performance, that assumption should be evaluated early.
The team may not need a fully assembled prototype to investigate it.
A bench test, simulation, component-level experiment or proof-of-concept assembly may provide enough evidence to decide whether the concept is worth pursuing.
The FDA's guidance on early feasibility medical device studies also recognises the importance of evaluating device functionality and addressing critical uncertainties during development, although its formal Early Feasibility Studies Program concerns clinical investigations rather than ordinary engineering feasibility assessments.
The underlying product-development lesson is relevant: the right evidence should be collected at the right stage.
3. Have You Considered Regulatory Requirements Before Starting Product Design?
Regulatory planning is often treated as an activity that begins after a medical device has been developed.
In practice, regulatory requirements can influence the design from the beginning.
A medical device intended for the Indian market may be subject to requirements under the Medical Devices Rules, 2017, administered by the Central Drugs Standard Control Organisation (CDSCO).
Devices are classified into four risk categories:
Class A: Low risk
Class B: Low-moderate risk
Class C: Moderate-high risk
Class D: High risk
The applicable regulatory pathway depends on factors including the device's intended use, classification and other relevant requirements.
For companies planning to enter the United States, the FDA's regulatory framework introduces additional considerations.
Depending on the device, the applicable marketing pathway may involve 510(k) clearance, De Novo classification or Premarket Approval (PMA).
These pathways are not interchangeable, and not every device follows the same requirements.
For example, a product intended to perform a diagnostic function may require a different evidence strategy from a device used solely for monitoring or supporting an existing procedure.
The materials selected, software architecture, intended users and clinical claims can all affect the development and regulatory strategy.
There is also an important distinction between regulatory planning and regulatory authorization.
A feasibility study can help identify likely requirements and development implications, but it does not establish that a device will receive regulatory clearance or approval.
For startups, early regulatory input can help avoid design decisions that later require substantial changes.
This is especially relevant for companies planning to launch in more than one country.
A product developed exclusively around one market's requirements may need modifications to support entry into another.
Regulatory feasibility should inform the product-development plan before the team commits to expensive design decisions.
4. What Could Go Wrong, and How Will You Evaluate the Risks?
Every medical device involves some degree of risk.
The objective is to identify foreseeable hazards, understand their potential consequences and determine how those risks can be controlled.
ISO 14971:2019 provides an internationally recognised framework for medical device risk management.
The standard covers the identification of hazards, estimation and evaluation of risks, implementation of risk controls and monitoring throughout the device lifecycle.
It was reviewed and confirmed in 2025 and remains current.
For an early-stage medical device, risk assessment may reveal issues that influence the fundamental design.
Consider a device containing moving mechanical components.
The engineering team needs to consider what happens if a component becomes jammed, if the mechanism applies excessive force or if a part fails during use.
For an electronic medical device, risks may involve electrical safety, battery performance, overheating or software malfunction.
For a device that comes into contact with the patient, material selection and biological safety may be important.
These issues cannot always be resolved simply by adding warnings to the final product.
Some risks may require changes to the mechanical design, materials, electronics or operating mechanism.
This is why risk management should be integrated into feasibility assessment rather than introduced after the first prototype has been completed.
Early risk analysis also helps prioritise development work.
If one technical assumption could create a serious safety concern, the team may need to investigate it before spending resources on enclosure design, aesthetics or secondary features.
A feasibility study should not claim that the product is safe based on limited early evidence.
It should identify the important risks, potential controls and additional testing required as development progresses.
5. Can the Device Be Manufactured at the Intended Cost and Scale?
A prototype can demonstrate that a product concept works without demonstrating that the product can be manufactured commercially.
This is one of the most important distinctions in medical device development.
A prototype may rely on 3D-printed components, manually assembled electronics or custom-machined parts.
These methods are valuable during development because they allow engineers to test ideas and make changes quickly.
However, they may not be suitable for commercial production.
Consider a medical device enclosure developed through 3D printing.
The design may perform well during initial testing. But when the company decides to move toward injection moulding, several issues can emerge.
Wall thickness may need to change. Draft angles may be required. Component interfaces may need to be redesigned. Assembly methods and material choices may also need to be reconsidered.
A product that was straightforward to prototype can become significantly more challenging to manufacture.
Manufacturing feasibility should therefore consider the intended production process early.
The assessment may include component availability, material selection, assembly complexity, supplier capabilities, tooling requirements, tolerances, quality controls and estimated production volumes.
For example, a product intended for 100 units per year may justify a different manufacturing approach from one intended for 10,000 units annually.
The expected volume influences decisions about tooling investment, manufacturing methods and unit economics.
Design for Manufacturing (DFM) helps address these considerations during product development.
It does not mean finalising every manufacturing decision before the first prototype.
It means recognising major production constraints before the design becomes expensive to change.
For founders, this can be particularly valuable when preparing development budgets.
The cost of a functional prototype and the cost of creating a commercially manufacturable medical device are two different calculations.
6. Does the Product Make Commercial Sense Beyond the First Prototype?
Technical feasibility is only one part of determining whether a medical device concept is worth pursuing.
The company also needs to understand whether the product has a realistic path to market.
A device may solve a genuine clinical problem and still face commercial challenges.
The intended customers may be unwilling to pay the required price. Hospitals may already have established procurement arrangements. Competing products may offer similar functionality at a lower cost.
Alternatively, the proposed device may require a level of training, servicing or infrastructure that makes adoption difficult.
Commercial feasibility should examine the intended customer, purchasing process, competitive alternatives, expected selling price and cost structure.
For medical device startups, it is useful to distinguish between the user and the buyer.
A clinician may strongly support a product because it improves a procedure, while the hospital's procurement team evaluates it based on cost, service support, maintenance and purchasing priorities.
Both perspectives matter.
A feasibility assessment should also consider the broader development investment.
The first prototype is rarely the final expense.
Additional costs may arise from engineering iterations, verification and validation, tooling, regulatory activities, clinical evaluation where required and manufacturing preparation.
This makes it important to understand how much investment may be required beyond the initial proof of concept.
A founder does not need a perfectly accurate commercial forecast before starting development.
However, the team should have a reasonable understanding of the intended market, expected price range, major cost drivers and the assumptions that could affect commercial viability.
The objective is to determine whether the potential opportunity justifies further investment.
What Should a Medical Device Feasibility Study Include?
A medical device feasibility study should provide enough evidence to support an informed development decision.
Depending on the device's complexity and intended use, the assessment may include:
Assessment area | Expected output |
Clinical feasibility | Defined clinical need, users and intended benefits |
Technical feasibility | Engineering approach, critical components and unresolved technical risks |
Regulatory feasibility | Preliminary classification and likely regulatory requirements |
Safety and risk | Initial hazards, risk considerations and required evaluations |
Manufacturing feasibility | Potential production methods, material considerations and major cost drivers |
Commercial feasibility | Target market, customer needs, estimated costs and commercial assumptions |
The output does not need to be an excessively long report.
It needs to make the important uncertainties visible.
A useful feasibility assessment should also identify which assumptions have been supported by evidence, which remain unresolved and what work is required next.
For example, the team may conclude that the core sensing technology is technically viable but that additional testing is required to evaluate performance under realistic operating conditions.
That is a useful outcome.
It allows the company to make a focused investment rather than committing immediately to full product development.
How Long Does a Medical Device Feasibility Study Take?
There is no universal timeline for a medical device feasibility study.
The duration depends on the complexity of the product, the availability of technical information, the novelty of the technology and the level of testing required.
A relatively straightforward mechanical device may need a different assessment from an implantable device, an AI-enabled diagnostic system or a product combining multiple sensing technologies.
The scope also matters.
A preliminary feasibility assessment based on existing technical information is different from one requiring laboratory experiments, component testing or extensive engineering simulations.
For founders, the better approach is to define the questions the study must answer and estimate the work needed to answer them.
A feasibility study should be proportionate to the investment decision being made.
It should provide enough information to determine whether the next development stage is justified without attempting to complete the entire product-development programme prematurely.
Feasibility Study vs Proof of Concept vs Prototype: What's the Difference?
These terms are often used interchangeably, but they serve different purposes.
A feasibility study evaluates whether a medical device concept is worth pursuing and identifies the main clinical, technical, regulatory, manufacturing and commercial uncertainties.
A proof of concept (PoC) tests whether a particular technical principle or critical function can work. It may involve a simple experiment, simulation or limited assembly rather than a complete product.
A prototype is a physical or digital representation of the proposed device used to evaluate aspects of its design, functionality, usability or performance.
These activities can overlap.
For example, a feasibility study may include a small proof-of-concept experiment. A prototype may also be used to investigate unresolved feasibility questions.
The important distinction is the purpose of the work.
A feasibility study helps determine what needs to be proven. A proof of concept investigates whether a specific idea works. A prototype helps the team evaluate and refine the developing product.
Why Feasibility Matters Before Medical Device Prototyping
Medical device development involves uncertainty. That is unavoidable, particularly when companies are working on novel technologies or clinical applications.
What can be managed is the order in which that uncertainty is addressed.
A team that begins with detailed product design may make considerable progress before discovering a problem with a critical component, material or manufacturing process.
Another team may spend more time evaluating those assumptions at the beginning and enter prototyping with a clearer understanding of the technical constraints.
Neither approach guarantees commercial success.
However, early feasibility work can help companies direct engineering resources toward the questions that matter most.
The FDA's approach to early feasibility clinical investigations reflects a related principle: appropriately planned early evaluation can help identify necessary design modifications, understand device functionality and inform subsequent development.
It is important to distinguish this formal clinical study framework from a pre-prototype engineering feasibility study. They serve different purposes and may have different regulatory obligations.
For founders, the practical lesson is that development should progress through evidence rather than assumptions alone.
A successful feasibility study may lead to prototype development. It may also lead to a revised concept, a different technology choice or a decision not to proceed.
All three can be valuable outcomes when they prevent larger investments from being made without sufficient evidence.
Before You Build the Prototype, Understand What You're Building
A medical device prototype is an important milestone, but it is not the starting point for every product-development decision.
Before committing to the first build, companies should understand the clinical problem, evaluate the technical approach, identify relevant regulatory and safety considerations, and consider how the product could eventually be manufactured and commercialised.
The goal is not to eliminate every uncertainty before development begins.
It is to identify the uncertainties that could materially affect the product's success and address them in a sensible order.
For medical device founders, that can make the difference between building a prototype to explore an idea and building one with a clear development objective.
Planning to Develop a Medical Device?
At Inspire Design, we have worked across 60+ healthcare product development projects, supporting clinicians, startups and medical device companies through industrial design, product engineering, prototyping and Design for Manufacturing.
Our work focuses on translating early-stage product ideas into practical engineering solutions while considering usability, technical feasibility and manufacturing requirements.
If you're evaluating a new medical device concept or preparing to invest in prototype development, an early engineering discussion can help identify important technical and design considerations.
Frequently Asked Questions
What is a medical device feasibility study?
A medical device feasibility study evaluates whether a proposed medical device is clinically relevant, technically achievable, safe, manufacturable and commercially viable. It identifies critical assumptions and risks before significant investment in product development.
Why is a feasibility study important before prototyping?
A feasibility study helps identify technical limitations, regulatory considerations, safety risks and manufacturing constraints before they become expensive design problems. It also helps determine what the first prototype should test.
How much does a medical device feasibility study cost?
The cost depends on the complexity of the device, the scope of engineering work, the need for testing or simulations and the expertise required. There is no universal cost applicable to all medical device concepts.
How long does a medical device feasibility study take?
The timeline varies depending on product complexity, available information and the extent of technical evaluation required. Studies involving novel technologies, extensive testing or multiple engineering disciplines generally require more work than preliminary assessments of established technologies.
Can a feasibility study be conducted without building a prototype?
Yes. Many feasibility questions can be investigated through engineering analysis, literature review, simulations, component evaluation, supplier discussions and regulatory assessment. Some concepts may require proof-of-concept testing to resolve critical technical uncertainties.
What is the difference between a feasibility study and a prototype?
A feasibility study determines whether a product concept is worth pursuing and what uncertainties need to be resolved. A prototype is used to test and refine the product's design, functionality or usability.
Who should be involved in a medical device feasibility study? Depending on the product, the team may include clinicians, biomedical engineers, mechanical and electronics engineers, industrial designers, regulatory specialists, quality professionals and manufacturing experts.
Disclaimer: This article provides general information about medical device feasibility and product development. It does not constitute regulatory, clinical or legal advice. Requirements vary by device, intended use and target market.
Comments